Filter Results:
(4)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (249)
- Research (607)
- Events (7)
- Multimedia (24)
- Faculty Publications (393)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (249)
- Research (607)
- Events (7)
- Multimedia (24)
- Faculty Publications (393)
Page 1 of 4
Results
- Profile
Avi Kremer
millions of dollars into research, and removed critical barriers to the development of treatments. “Our focus was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed in 2004, just weeks into his first year at... View Details
- Profile
Arjun Goyal
“marries a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical... View Details
- Profile
Henry McCance
a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had spent 40 years as eyewitness to advances in technology that changed the world at... View Details
- Profile
Kanwaljit Bakshi
her dual law and business degrees to fight some of the world's most disturbing criminals. Since 2011, Brochu, 42, has been the United Nations Office on Drugs and Crime's Expert on Child Exploitation and Human Trafficking, a position she... View Details
Keywords: Nonprofit / Government